首页 | 本学科首页   官方微博 | 高级检索  
     


palliative care and end-stage colorectal cancer management:The surgeon meets the oncologist
Authors:Renato Costi  Francesco Leonardi  Daniele Zanoni  Vincenzo Violi  Luigi Roncoroni
Affiliation:Renato Costi;Francesco Leonardi;Daniele Zanoni;Vincenzo Violi;Luigi Roncoroni;Istituto di Clinica Chirurgica Generale e Terapia Chirurgica,Dipartimento di Scienze Chirurgiche,Università di Parma,Azienda Ospedaliero-Universitaria di Parma,43126 Parma,Italy;Dipartimento Polispecialistico 1,Unità Operativa di Oncologia Medica,Azienda Ospedaliero-Universitaria di Parma,43126 Parma,Italy;Dipartimento di Chirurgia Generale e Specialistica,Ospedale di Vaio,Azienda Unità Sanitaria Locale di Parma,43036 Fidenza (Parma),Italy;
Abstract:Colorectal cancer (CRC) is a common neoplasia in the Western countries, with considerable morbidity and mortality. Every fifth patient with CRC presents with metastatic disease, which is not curable with radical intent in roughly 80% of cases. Traditionally approached surgically, by resection of the primitive tumor or stoma, the management to incurable stage IV CRC patients has significantly changed over the last three decades and is nowadays multidisciplinary, with a pivotal role played by chemotherapy (CHT). This latter have allowed for a dramatic increase in survival, whereas the role of colonic and liver surgery is nowadays matter of debate. Although any generalization is difficult, two main situations are considered, asymptomatic (or minimally symptomatic) and severely symptomatic patients needing aggressive management, including emergency cases. In asymptomatic patients, new CHT regimens allow today long survival in selected patients, also exceeding two years. The role of colonic resection in this group has been challenged in recent years, as it is not clear whether the resection of primary CRC may imply a further increase in survival, thus justifying surgery-related morbidity/mortality in such a class of short-living patients. Secondary surgery of liver metastasis is gaining acceptance since, under new generation CHT regimens, an increasing amount of patients with distant metastasis initially considered non resectable become resectable, with a significant increase in long term survival. The management of CRC emergency patients still represents a major issue in Western countries, and is associated to high morbidity/mortality. Obstruction is traditionally approached surgically by colonic resection, stoma or internal by-pass, although nowadays CRC stenting is a feasible option. Nevertheless, CRC stent has peculiar contraindications and complications, and its long-term cost-effectiveness is questionable, especially in the light of recently increased survival. Perforation is associated with the highest mortality and remains mostly matter for surgeons, by abdominal lavage/drainage, colonic resection and/or stoma. Bleeding and other CRC-related symptoms (pain, tenesmus, etc.) may be managed by several mini-invasive approaches, including radiotherapy, laser therapy and other transanal procedures.
Keywords:Colorectal cancer   Palliative care   Multimodal treatment   Chemotherapy   Surgery   Stenting   Radiotherapy
本文献已被 CNKI 等数据库收录!
点击此处可从《World journal of gastroenterology : WJG》浏览原始摘要信息
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号